干扰在治疗骨髓增殖性新生瘤的干扰
Pankit Vachhani1, John Mascarenhas2, Prithviraj Bose3
1Hematology Oncology at The Kirklin Clinic of UAB Hospital, North Pavilion, Room 2540C, 1720 2 Ave S, Birmingham, AL 35294-3300, USA.
Therapeutic advances in hematology
|February 21, 2024
概括
基化干扰素通过增强稳定性和降低毒性,为髓增殖性瘤 (MPNs) 提供了改进的治疗方法. 本综述检查了MPN患者的疗效,安全性和实际管理.
科学领域:
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
- 药理学 药理学是指药理学的学科.
背景情况:
- 干扰素 (IFN) 是具有免疫调节和疾病修饰作用的细胞因子,已用于骨髓增殖性瘤 (MPNs) 超过35年.
- 最初的IFN使用受到管理挑战和毒性的限制.
- IFN的化增强了稳定性,延长了活性,并降低了免疫性.
研究的目的:
- 审查MPN治疗中干扰素α-2a和干扰素α-2b-njft最近的疗效,分子反应和安全数据.
- 讨论基于干扰素的疗法的实际管理,包括从基尿素切换.
- 检查有关安全性,耐受性,变异性等位基因频率,早期治疗益处以及MPN中干扰素治疗的未来的关键问题.
主要方法:
- 对基化干扰素 (pIFN) 的最新临床数据的审查.
- 对疗效,分子反应和安全性概况的分析.
- 讨论实际的管理策略和治疗转换.
主要成果:
- 建议对真多细胞血症,精性血栓细胞血症和原发性骨髓纤维化症使用佩吉化干扰素.
- 介绍了有关干扰素α-2a和干扰素α-2b-njft有效性和安全性的最新数据.
- 讨论了转换治疗的管理策略和考虑因素.
结论:
- 基化干扰素是MPN的重要治疗选择.
- 需要进一步的研究来优化对MPN的干扰素治疗.
- 安全性,耐受性和早期治疗的好处等关键方面需要继续调查.
更多相关视频
相关概念视频
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
Antimicrobial Proteins
990
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
990
Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
Role of Hematopoietic Growth Factors
1.4K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.4K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Immune Response Against Viral Pathogens
782
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
782


